ARTICLE | Company News
PTC sales and marketing update
December 15, 2014 8:00 AM UTC
PTC launched Translarna ataluren in Germany to treat nonsense mutation Duchenne muscular dystrophy (DMD). The product is a small molecule that facilitates complete translation of proteins containing ...